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ABSTRACT 
Tuberculosis (TB), the most deadly global single organism infectious disease, kills nearly twice as many men as women. 
Understanding the factors that drive this bias in TB mortality is an important aspect of the global effort to reduce the enormous 
burden of this disease in the developing world. One third of the world’s population is estimated to be infected TB, with Low and 
Middle Income Countries (LMIC) bearing the greatest disease burden. In LMIC sex bias in TB is influenced by sociocultural, 
behavioural as well as biological factors, with dynamic interactions between reporting variables, other confounding variables and 
physiological mechanisms, which each influence one another to produce the male-biased sex ratio observed in TB transmission, 
prevalence and mortality. While confounding factors are addressed in the existing global drive to tackle TB it is the biological 
aspects of sex bias in TB that present specific challenges for diagnosis and treatment in men and women as they potentially 
influence future immunological-based interventions to treat TB.  
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INTRODUCTION 
Global prevalence of tuberculosis 
One third of the world’s population is estimated to be infected with latent tuberculosis (TB), with 10% progressing to active 
infection over their lifetime. In 2017, 10 million people fell ill with TB, with 1.3 million deaths.1 Globally, TB is one of the top 10 
causes of death and the leading cause of death from a single infectious agent (above HIV/AIDS). While Africa has the highest 
incidence rate of TB (236 cases per 100,000 people in 2017) the majority of patients with TB live in the most populous countries 
of Asia (52%).  
 
TB incidence is correlated with a weak immune system, as this increases the chance of active infection.2 Factors which increase 
the chance of active infection are: HIV, malnutrition, smoking and alcohol abuse, and are all associated with living in a LMIC. 
The common pattern of migration seen in LMIC from rural to highdensity areas, increases transmission rates.3 Even though a re-
emergence of TB in LMIC is related to migration of young adults, the age class with the highest TB rates are adults over 45 years 
old due, in part, to birth rate decreases as longevity and education improve in LMIC.4 There has been a resurgence of TB in 
Eastern Europe since the 1990s with the fall of the Soviet Union and subsequent economic decline and political instability that 
resulted in an inadequate public health approach to TB control. Limited and substandard quality first and second-line drugs 
contributed to the increase of multi- and extensively-drug resistant TB (MDR- and XDR-TB) in Eastern Europe. MDR-TB are 
strains of TB which are resistant to at least two front-line drugs: isoniazid and rifampicin, while XDR-TB is additionally resistant 
to any fluoroquinolone and at least one injectable second-line drug (i.e. amikacin). Currently, only 3% of the global burden of TB 
but 20% of the MDR-TB is found in the European region, primarily Eastern Europe.1 
 
In Africa, the rapid rise in HIV infection rates in the 1980s contributed to the resurgence of TB on the continent.5 Normally only 
5-10% of infected individuals develop TB in their lifetime, however when co-infected with HIV the risk of reactivating a latent 
TB infection increases to 5-15% annually.6 In 2017, 1 in 3 HIV deaths were due to TB and globally 9% of TB cases were co-
infected with HIV.1 The main factor associated with TB recurrence in people living with HIV in Africa was baseline CD4 count.7 
There is significantly lower HIV-specific T-cell function in co-infected individuals compared with HIV mono-infected individuals, 
which means that the TB bacilli are not restricted to a few infected macrophages. This results in an increased HIV disease 
progression in TB/HIV co-infected individuals and reactivation of latent TB. 
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Sex bias in TB epidemiology has been shown to be influenced by many variables including HIV disease progression, as HIV 
disproportionately impacts young women aged 15-24 years.8 Social sexual inequality can also influences rates of MDR-TB, as 
shown in China where its severe sex ratio imbalances at birth9 have almost certainly influenced its development as a centre for 
MDR-TB and XDR-TB.10 Also differences in MDR-TB transmission between the sexes could have an additional impact on these 
dynamics. 
 
What role does sex bias have on the g lobal tuberculosis epidemic? 
Tuberculosis is about twice as prevalent in men as in women (Figure 1), with a global male:female sex ratio for TB of 1.7:1 in 
2017. Countries with the highest ratios are globally spread, from El Salvador (3.2:1), The Gambia (2.6:1), Moldova (2.5:1) and the 
Philippines (2.4:1).1 Sex bias is historically attributed to epidemiological factors, such as cultural and socioeconomic impacts 
leading to barriers in accessing healthcare.11 However, the definitive cause of this bias is unknown but biological differences 
between the sexes are shown to affect susceptibility to mycobacterial infection.12  
 
Figure 1. Global sex distribution for new cases of TB in 2017.1 Males (in dark red) have a greater incidence of TB compared to females (in green) in all regions. El 
Salvador, The Gambia, Vietnam and some Eastern European countries had some of the highest proportions of TB in males (70-76%). 
 
In an analysis of 29 studies in 14 countries, there were more TB cases in men than women in almost all cases13 which, as studies 
of sex bias in TB are predominantly undertaken in LMIC, suggest there is an impact of cultural and social factors. It has been 
reported that Directly Observed Treatment Short Course (DOTS) for TB, which requires direct supervision of patients taking 
medication, can result in a greater risk of drug resistance and transmission to contacts among women as some are unable to travel 
as often as needed to the DOTS clinic.14 However, a recent global study concluded that sex was not a risk factor for MDR-TB.15 
Given that confounding variables like access to clinics have been shown to affect the viability of treatment16, the incorporation of 
progressive treatment of TB into practice, such as working towards women patients administering their own medication, is 
important.  
 
Studies in High Income Countries (HIC) like the USA can controlled for reporting bias and so enabled trends due to biological 
differences between the sexes to be examined. One such study by Martinez et al.17 still showed a higher incidence of TB in men 
than women (2.1:1) even in HIV-negative populations, with the highest sex ratio in 45-64 year old adults. This is an age group 
when women are more likely than men to access healthcare14 so more likely to be identified as TB-positive, hence this study 
shows real epidemiological differences between the sexes. In addition, Martinez et al.17 found that the highest sex biases seen were 
in clusters of patients, meaning that within these clusters there is a higher chance of infection and higher rates of progression 
from latent to active infection. This conclusion was supported by Cattamanchi et al.18 who showed that being male was linked 
with clustering in mycobacterial genetic analyses. These studies conclusively state that differences they detected in TB rates were 
due to the dynamics of TB transmission and not reporting bias. 
 
 
Males 
Females  
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Is there evidence that reporting bias affects the sex ratio in tuberculosis? 
Healthcare in LMIC is often less accessible to women, due to factors such as childcare and inability to travel alone to 
appointments19 leading to the suggestion that, in some cases, the epidemiological differences seen between the sexes could be due 
to reporting bias rather than biology. There is evidence that existing methods of TB detection have higher failure rates in 
women.16 Specifically, the most widely used detection method, the tuberculin skin test, is less sensitive at detecting TB in women 
than in men12 and in a randomised trial of TB detection by the sputum smear test found that women completed the test 
incorrectly significantly more often than men.20 However, when the instructions for the sputum smear test were clearer, the gap in 
TB notification rates between the sexes was reduced. In addition, men with a cough were significantly more likely to receive a 
sputum smear examination than women.21 Studies in Vietnam have found that female cases were significantly more likely to go 
undetected, with women being diagnosed on average two weeks later than men due to delays from healthcare providers.22 These 
results highlight how, on average, TB notification rates are lower for women than for men even when in contact with healthcare 
providers.  
 
Conversely, in studies where reporting bias is either eliminated or less likely, there are still clear epidemiological differences 
between the sexes in prevalence of TB. A study carried out in South India using a report from a rural DOTS programme, found 
that even though men had higher rates of TB, women were significantly more likely to access healthcare services, be notified 
under DOTS and comply with full treatment.23 A national survey in Vietnam found that even though TB cases in women were 
more likely to be reported than male TB cases, the male to female ratio was still 5.1:1.24 In these particular studies women had 
higher access to healthcare, but men still had higher rates of TB cases. In these populations the disparity of prevalence of TB 
between the sexes must be mostly biological, so is there clear evidence to support a physiological difference between men and 
women in the prevalence and progression of TB? 
 
Do sex differences only affect disease progression of TB? 
Sex bias seen in TB cases may be partly due to differences in disease progression from latent to active TB infection rather than 
initial transmission of TB. It has been reported that women have higher rates of progression to active infection during their 
reproductive years, while in men higher rates of progression to active TB occur in their later years of life.14,25 There are many 
possible reasons for higher rate of disease progression among young women in their reproductive years. Stresses of pregnancy as 
well as the natural depression of immune function in order to protect the foetus can contribute to disease progression. However, 
studies, including case controlled studies, have failed to show a link between pregnancy and TB.26-28 Newly infected people have a 
greater chance of progression to active infection than those with an older infection.29 Higher rates of progression to active TB in 
reproductive-age women could be linked to the lower rates of TB cases in adolescent women compared to adolescent men. 
Therefore, women are more likely than men to be newly infected during their reproductive years and so more likely to progress to 
an active infection. In addition, higher rates of progression to active TB infection among older men could be due to sex specific 
variables, such as smoking or heavy alcohol consumption, which are more common in men and can lead to reduced immune 
function and increased disease progression of TB.30 Thus, evidence shows that women in their reproductive years have higher 
disease progression than men, so the lower notification rates seen for women appear not to be due to a lower disease progression 
to active TB.13 
 
Can the sex ratio be attributed to confounding variables? 
Confounding variables could be the basis of sex bias leading to differential TB rates between men and women. Behaviour has 
been proven to affect exposure to TB, with men more likely to have a greater number of social contacts and, in LMIC, have 
professions with higher risks of infection, such as mining, compared to women.31 Household contact with infected individuals is a 
strong risk factor for TB32 but even though women typically spend more time at home in LMIC, men still remain at a higher risk 
of acquiring TB from a household contact.33 
 
The prevalence of HIV/AIDS varies by region and between men and women (UNAIDS, 2014). HIV has been discussed as a 
variable which impacts differential TB incidence between the sexes in a study carried out in San Francisco. As discussed above, 
TB rates were higher among men than women even in HIV-negative populations in a study that eliminated reporting bias.17 
HIV/TB co-incidence dynamics can give an insight into sex bias, and can also be influenced by the sex differences seen in 
HIV/AIDS prevalence. A review on TB sex bias and transmission of HIV in Shanghai found that TB infections of men are 
linked to higher rates of HIV in the population.34 From this it is clear that there is a viable case for sex differences potentially 
affecting TB transmission and the interaction between TB and HIV/AIDS. Fifteen percent of women living with HIV are 15-24 
year olds and 80% live in Sub-Saharan Africa. As HIV disproportionately affects young women in Africa, it is critical to 
investigate whether this variable influences TB disease dynamics in reproductive women. A study in Tanzania found that HIV 
infection among smear-positive TB cases was higher in women than men in the 15-34 years age range.35 In Zambia it was found 
that 74% of women aged 14-24 years were HIV-positive compared to 48% of men of the same age. After 24 years of age, there 
was a higher number of male TB cases, but the prevalence of HIV was similar in all people with TB.36 These results show the sex 
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bias seen in TB in the presence of HIV, and demonstrates that even in cases where HIV is more prevalent in women, TB cases 
are still higher in men.  
 
Confounding variables, like behaviour, HIV and pregnancy can affect TB disease dynamics. These variables can lead to an 
increased rate of transmission, as well as increased TB disease progression. The co-related disease dynamics. The implementation 
of TB testing in HIV clinics could result in increased numbers of successful TB treatments. As much is still unknown regarding 
the disease dynamics of TB and HIV, and their interactions, diagnostics in low resource clinical settings need to improve rapidly. 
 
Physiolog ical mechanisms of sex bias 
While analysis of behaviour offers some explanation for the sex differences seen in TB transmission and prevalence, analysis of 
physiology provides stark evidence for how biological differences between the sexes result in men being more susceptible than 
women to TB infection, as well as an explanation for increased disease progression seen in men. 
 
Sex-specific gene architecture 
Sex-specific gene architecture has been demonstrated to have a major effect on susceptibility to TB infection and disease 
progression in humans37, while the use of rodent models has enabled investigation of specific genes known to respond to 
mycobacterial infection.38 Genome-wide linkage analyses have identified dominant loci on chromosome 8 and the X-chromosome 
that appear to confer a predisposition to TB in adults.39,40 Polymorphisms of the transport protein NRAMP1 were linked to 
reduced TB susceptibility in young adult women41 and that the risk of developing TB was linked to polymorphisms in specific 
toll-like receptors (TLR), which are responsible for cellular recognition of microbial structures and so influence immune response 
to infection.42 X chromosome-linked TLR8 gene polymorphisms have been linked to susceptibility to TB infection especially in 
male children43 and 2 other X-chromosome linked genes, IKBKB and CYBB, are part of a group of 9 genes known to be 
associated with susceptibility to mycobacterial disease.44 Gene-dosing effects in women have been proven to be beneficial in 
terms of reduced TB susceptibility as about 15% of X-linked genes can escape silencing. This can lead to the increased expression 
of these genes in women45, including immunomodulatory micro-RNAs (miRNAs), which are far more numerous on the X 
chromosome compared to the Y chromosome.46 It is clear that investigation of expression of X-linked genes and miRNAs could 
lead to a better understanding of sex-specific susceptibility to TB infection. 
 
The role of Sex steroids and nutrition in differential TB susceptibility. 
In many infectious diseases females exert a greater immune response to foreign antigens than males44, with sex steroid hormones 
playing a role in this differential immune responses (Figure 211,47). Therefore, sex hormones could be a significant factor for sex 
bias in TB. Testosterone impairs pro-inflammatory cytokine production48, whereas oestrogens are a pro-inflammatory inducer.49 
In TB-infected mouse models, non-castrated males had higher mortality, higher bacilli burdens, less inflammation in lung 
compartments and lower cytokine production compared to female and castrated male mice.50 
 
Activated macrophages are thought to have an important role in the immune response to TB infection through the destruction of 
M. tuberculosis (Mtb) bacilli.51 While the oestrogen sex steroid estradiol enhances macrophage activation52, testosterone reduces 
macrophage activation through down-regulation of TLR4 expression.44 Apoptotic cell death of Mtb-infected macrophages is vital 
for Mtb control and decreases bacterial growth, whereas necrotic cell death promotes bacterial growth. Apoptotic and necrotic 
cell death is balanced through the regulation of prostaglandin (PGE2; pro-apoptotic) and lipoxin A4 (LXA4; pro-necrotic) 
activity.53 The sex hormone progesterone can increase PGE2 production by monocytes, while testosterone inhibits PGE2 
production54 suggesting sex differences in macrophage regulation and a basis for sex differences in TB infection and progression. 
 
While macrophages appear to have a central role in TB immune response, neutrophils are thought to be the dominant infected 
cell type in the upper respiratory tract during active TB.56 Lyadova57 suggested that TB disease dramatically alters neutrophil 
population, leading to the accumulation of heterogeneous subsets of immature and activated dysfunctional cells and a decline in 
true neutrophils. Interferon (IFN) secretion is shown to be driven by neutrophils in active TB infection.58 0LFH ODFNLQJ ,)1ƣ RU 
WKH ,)1ƣ UHFHSWRU VKRZHG LQFUHDVHG VXVFHSWLELOLW\ WR 0WE LQIHFWLRQ WKURXJK LQFUHDVHG UHFUXLWPHQW RI 0WE-infected neutrophils 
into the lungs,59 highlighting the importaQFH RI ,)1ƣ LQ 7% 1HXWURSKLO UHFUXLWPHQW FDQ EH PRGXODWHG E\ PL51$ SDUWLFXODUO\ WKH 
X-chromosome linked miRNA-223 which downregulates CXCL2 and CCL3 in neutrophils, and so reduces their recruitment into 
lungs. Deletion of miRNA-223 results in increased susceptibility to Mtb infection due to pathogenic neutrophil recruitment in the 
lungs, leading to tissue damage.60 Incomplete gene silencing in females often leads to higher expression levels of miRNA-223 and 
so lower pathogenic recruitment of neutrophils compared to males. Progesterone and oestrogen decrease spontaneous neutrophil 
apoptosis in females,61 whereas testosterone increases neutrophil activation in males.62 Sex steroids have also been linked to 
structural and histological differences of the upper airway and respiratory tract between the sexes.63,64 Therefore, understanding 
the influence of sex steroids on immune responses and physiology are critical to determining the biological basis of sex bias in TB. 
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Figure 2. How sex steroids influence mycobacterial immunity. Immune cells and T-cells express receptors for steroid hormones on their cell surface.55 Sex 
steroids can influence M. tuberculosis (Mtb) entry (1) and intracellular trafficking (2) in host phagocytes and antigen-presenting cells. Sex steroids can modulate the 
secretion of cytokine and growth factors by Mtb infected cells (3), can result in antigen presentation (4) and T-cell development (5). Figure taken from Neyrolles & 
Quintana-Murci (2009).11 
 
Nutrition and metabolism could impact the susceptibility to Mtb infection, as sex differences in nutrition can be linked to immune 
function.65,66 In the developing world malnutrition is a major concern, for example, iron deficiency in women is an important 
issue in LMIC.67 Studies have shown that iron overload increases susceptibility to Mtb infection, both in vivo68 and in vitro.69 Iron is 
a critical component of microbial enzymes and redox systems70 and has been linked to immune system mechanisms to control 
pathogens, such as mycobacteria.71 Vitamin D has been reported to mediate an antimycobacterial response through the triggering 
of TLRs72 and oestrogen has been linked to vitamin D-mediated resistance.73 A case-control study among Gujarati Asians living in 
west London, UK, found that vitamin D deficiency and receptor polymorphisms had a major influence on susceptibility to TB.74 
 
Sex differences in treatment 
As physiological differences between the sexes can result in differential susceptibility to Mtb infection and progression to active 
infection, it is possible that treatment would have different outcomes between the sexes due to sex-specific mechanisms as well. 
For example, a Ugandan study investigating sex differences in the presentation and outcomes of HIV-infected adults with TB, 
found that there were differences of TB incidence rates between the sexes at presentation. However, 1 year after the start of TB 
treatment outcomes were similar, suggesting there were no differential treatment effects between men and women.75 In contrast, a 
study in West Bengal, India, found there was a statistically significant difference between treatment outcomes in men and women, 
with more women successfully treated compared to men.76 In both of these studies, confounding factors were eliminated 
indicating it is still unclear whether sex-bias influences success rates in TB treatment. 
 
Social factors can also influence treatment outcome, as completion of TB treatment has been reported to be affected by various 
factors including sex and impact of HIV/AIDS77, although these data are somewhat contradictory. Hudelson14 reported lower 
treatment compliance of women compared to men as women were impacted more severely by the stigma associated with TB. In 
contrast, a four-country (Bangladesh, India, Malawi and Colombia) WHO study found that there were higher dropout rates in 
men than women due to distress caused by fear of stigma and rejection.78 Financial impact, hospitalization due to the disease and 
difficulties in attending clinics during opening times are suspected to be major causes for failure in TB treatment completion in 
men23 and higher dropout rates among males than females were also reported in a more recent study in Taiwan.79 
 
A systemic review of qualitative research highlighted major social and cultural factors which influence TB treatment outcome, 
including poverty, gender discrimination and health service factors.77 This review found a correlation between the patients’ 
understanding of the treatment and a positive treatment outcome. In this review women were more motivated to adhere to 
treatment, which aligns with reports from other studies on health-seeking behaviour. Failure to complete first-line treatment is 
linked to the development of drug resistant Mtb strains. Previous treatment with a second-line injectable drug is the strongest risk 
factor for XDR-TB80, however various studies have linked being female as another major risk factor for MDR and XDR-TB.81,82 
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Treatment needs to be offered in ways that maximises patient adherence to improve positive TB treatment outcome rates. Social 
factors due to work schedules of men and fear of stigma for women need to be considered and addressed, in order to provide 
appropriate interventions for both sexes and reduce treatment dropout rates. Physiological mechanisms of sex bias need to be 
better understood so that healthcare providers can offer optimal treatment for each sex to improve cure rates. 
 
CONCLUSION 
Despite recent efforts TB is still a leading cause of death worldwide, killing more than a million individuals each year. Though 
seemingly dormant in developed countries since the introduction of the BCG vaccine in the 1950s, TB re-emerged in parts of 
Europe and the developing world due to various confounding variables. The rise of HIV in Africa in the 1980s led to a rapid rise 
in TB rates, while socio-economic decline from the fall of the Soviet Union in the 1990s resulted in poor living conditions and 
healthcare provision, leading to MDR/XDR-TB. With increasing global migration and mobility between regions a rise in TB 
notification rates in the developed world is likely to occur in the future. 
 
The 2018 WHO Global TB report, documented a staggering 54 million lives saved between 2000 and 2017 due to effective 
diagnosis and treatment, alongside a 42% drop in mortality due to TB.1 The evidence discussed here points to an epidemiological 
sex bias in the transmission and prevalence of tuberculosis. A complex mixture of biological and cultural factors underlie a stark 
differential susceptibility to TB infection and progression to disease between males and females. Reporting bias due to cultural 
factors can contribute to lower notification rates of TB infection in women19, however reporting bias is not strong enough to 
explain the differences in male and female susceptible to TB. HIV is known to modulate TB susceptibility5, so high rates of HIV 
in regions such as Sub-Saharan Africa83 are likely to influence TB rates in these populations. However, higher TB rates in men 
than women in HIV-negative populations17 show that sex bias is important in TB epidemiology. 
 
Much work needs to be done to understand the relationship between sex and TB, as the physiological mechanisms behind 
immune responses and immunity to TB in men and women are unclear. It is highly likely that there is an interplay between 
physiological mechanisms influenced by sex-specific gene architecture, differential immune responses, and nutrition alongside 
confounding variables influenced by cultural factors, HIV prevalence, and MDR/XDR-TB prevalence, which are responsible for 
the male-biased sex ratio reported globally in TB. Improved knowledge of the role of sex steroid hormones in immunity will 
greatly improve understanding of how sex influences resistance to TB.  
 
The WHO End TB Strategy plans to end the global TB epidemic, with targets to reduce TB deaths by 95% and to cut new cases 
by 90% by 2035.1,84 Reaching these targets could be assisted by immunological and epidemiological research of sex bias. These 
future developments could impact the intervention of vaccines and other immunological approaches to improve TB cure rates, 
and ultimately lead to better education and knowledge of TB transmission and disease progression between the sexes, resulting in 
improved TB notification rates in men and women and a more effective strategy to tackle TB globally. 
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PRESS SUMMARY 
One third of the world’s population is estimated to be infected with tuberculosis (TB), a disease that affects twice as 
many men than women. We consider the different sociocultural, behavioural and biological factors that may produce 
this bias and consider how this might affect TB Transmission and progression and the possibility of exploiting these 
sex differences to better target TB treatments.  
    
